Ike Ahmed

This user account status is Approved

Sessions


Wednesday 9.45 am-10.45 amRoom 216

Turkish Glaucoma Society - New Treatment Options for Glaucoma

Chair(s): Kaweh Mansouri (Switzerland); Ilgaz Yalvac (Turkey);

  • 09.45-09.55
    New medical treatments for glaucoma
    Kivanç Güngör (Turkey)
  • 09.55-10.05
    Novel Drug Delivery Sytems
    Ahmet Akman (Turkey)
  • 10.05-10.15
    New Laser Treatment Options for Glaucoma
    Oya Tekeli (Turkey)
  • 10.15-10.25
    Xen Implant
    Kaweh Mansouri (Switzerland)
  • 10.25-10.35
    New MIGS Options
    Ike Ahmed (Canada)
  • 10.35-10.45
    Discussion

Wednesday 11.45 am-12.45 pmPlenary 2

Game Changers in Glaucoma

Chair(s): Keith Martin (United Kingdom); Makoto Araie (Japan); Robert Weinreb (United States); Winifred Nolan (United Kingdom);

Wednesday 1.00pm-2.00pmPlenary 2

SANTEN - Innovation in surgical management of glaucoma

Chair(s): Nathan Kerr (Australia);

Thursday 7.30 am-8.30 amRoom 203 & 204

iSTAR Medical - Next Generation MIGS enhancing Glaucoma Outcomes

Chair(s): Ike Ahmed (Canada);

  • 07.30-07.40
    Understanding surgical augmentation of suprachoroidal outflow in the era of MIGS and Interventional Glaucoma
    Julian Garcia Feijoo (Spain)
  • 07.40-07.55
    Introducing a novel supraciliary MIGS: MINIject
    Steve Vold (United States)
  • 07.55-08.15
    One year results of MINIject STAR-I trial
    Ike Ahmed (Canada)
  • 08.15-08.25
    MINIject Clinical Trial Program - STAR
    Christoph Hirneiss (Germany)

Thursday 12.15 pm-1.15 pmPlenary 2

ALLERGAN - Rethinking Decision-Making in Glaucoma Management

Chair(s): Keith Martin (United Kingdom); Michael Coote (Australia);

Friday 7.30 am-8.30 amRoom 210 & 211

GLAUKOS - MIGS Transformed: New Global Data and Surgical Technique Optimization

Chair(s): Ike Ahmed (Canada);

Contact

Please contact our Professional Congress Organizer MCI for all your WGC-2019 questions

MCI Amsterdam
Schipluidenlaan 4
1062 HE Amsterdam
The Netherlands
www.mci-group.com
wgc@mci-group.com